1-4 of 4
Ekkehard Schutz
Close
Sort by
Journal Articles

FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation

Thomas Oellerich, Sebastian Mohr, Jasmin Corso, Julia Beck, Carmen Döbele, Helene Braun, Anjali Cremer, Silvia Münch, Johannes Wicht, Mark F. Oellerich, Gesine Bug, Hanibal Bohnenberger, Christina Perske, Ekkehard Schütz, Henning Urlaub, Hubert Serve
Journal: Blood
Blood (2015) 125 (12): 1936–1947.
https://doi.org/10.1182/blood-2014-06-585216
Published: 2015
Includes: Supplemental data
Journal Articles

Deciphering The Molecular Impact Of Myc Overexpression On B Cell Receptor Signaling and Its Implications For Burkitt Lymphoma Treatment

Thomas Oellerich, Jasmin Corso, Simone Lemeer, Ekkehard Schütz, Julia Beck, Stephan Lorenzen, Tim Beissbarth, Silvia Münch, Pascal Degenhardt, Michael Engelke, Christoph Lenz, Bernhard Küster, Henning Urlaub, Hubert Serve, MD
Journal: Blood
Blood (2013) 122 (21): 3018.
https://doi.org/10.1182/blood.V122.21.3018.3018
Published: 2013
Journal Articles

Personalized Genetic Monitoring of myeloma using analytic multivariate analysis of total Fully-Sequenced Circulating DNA

Brian GM Durie, MD, Julia Beck, Sundar Jagannath, MD, Howard B. Urnovitz, MD, Ekkehard Schutz, MD
Journal: Blood
Blood (2008) 112 (11): 5120.
https://doi.org/10.1182/blood.V112.11.5120.5120
Published: 2008
Journal Articles

Circulating Nucleic Acids in Multiple Myeloma: Presence of Non-Coding/ Intergenic DNA Reflects Disease Activity.

Brian G.M. Durie, MD, Sundar Jagannath, MD, Ekkehard Schutz, Howard Urnovitz, MD
Journal: Blood
Blood (2005) 106 (11): 5095.
https://doi.org/10.1182/blood.V106.11.5095.5095
Published: 2005